CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jan 14, 2014 · 10-Q · 45 days after period end · 0001303681-14-000003
| Metric | Q1 2013 | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|---|
| Net Income | -$13.34K | -$15.14K | -$10.25K | -$8.81K |
| EPS Diluted | $0.00 | -$0.02 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Nov 30, 2013 · filed Jan 14, 2014 · 45 d after period end
